Clinical Trials Browser

Phase 1 × emvododstat × Clear all

Leukemia, Myeloid, Neoplasms, Neoplasms by Histologic Type, Leukemia, Myeloid, Acute

NCT00508586 2016-03-03

PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer

Phase 1 Completed

33 enrolled

Breast

Breast Neoplasms

NCT01158300 2015-05-04

PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors

Phase 1 Completed

28 enrolled

CNS

Familial ependymoma, Astrocytoma, Medulloblastoma, Meningioma, Oligodendroglioma, Spinal Cord Neoplasms, Central Nervous System Neoplasms, Optic Nerve Glioma

Clinical Trials

Study of PTC299 (Emvododstat) in Relapsed/Refractory Acute Leukemias

PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer

PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors